RARE News — Page 3
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2014-06-10 | Current report | SEC filing | Ultragenyx Pharmaceutical Inc. filed Form 8-K | Ultragenyx Pharmaceutical Inc. filed Form 8-K covering items 7.01. |
| 2014-05-12 | Current report | SEC filing | Ultragenyx Pharmaceutical Inc. filed Form 8-K | Ultragenyx Pharmaceutical Inc. filed Form 8-K covering items 2.02,9.01. |
| 2014-03-24 | Current report | SEC filing | Ultragenyx Pharmaceutical Inc. filed Form 8-K | Ultragenyx Pharmaceutical Inc. filed Form 8-K covering items 2.02,9.01. |
| 2014-02-25 | Current report | SEC filing | Ultragenyx Pharmaceutical Inc. filed Form 8-K | Ultragenyx Pharmaceutical Inc. filed Form 8-K covering items 1.01,9.01. |
| 2014-02-05 | Current report | SEC filing | Ultragenyx Pharmaceutical Inc. filed Form 8-K | Ultragenyx Pharmaceutical Inc. filed Form 8-K covering items 5.03,8.01,9.01. |